Shasun Pharma approves conversion of 15 Lk convertible warrants into equity

Shasun Pharma has approved the conversion of 15 Lk convertible warrants into equity shares of the Company, which were issued to the promoters and directors on preferential basis at a price of Rs 75 per share including premium of Rs 73 per share after obtaining the in-principle approvals from the stock exchanges.

March 21, 2013 / 18:31 IST

Shasun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 21, 2013 has approved the conversion of 15,00,000 convertible warrants into equity shares of the Company, which were issued to the promoters and directors on preferential basis at a price of Rs. 75 per share including premium of Rs. 73 per share after obtaining the in-principle approvals from the stock exchanges.Source : BSE

Read all announcements in Shasun Pharma

first published: Mar 21, 2013 06:31 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Email address

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Shasun Pharma approves conversion of 15 Lk convertible warrants into equity

SCD

Subscribe to Tech Newsletters